Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Schmitz

Showing results (231-240 of 239) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 239 results.
American Journal of Medical Genetics|February 16, 1996
Common subtypes of idiopathic generalized epilepsies: lack of linkage to D20S19 close to candidate loci (EBN1, EEGV1) on chromosome 20T Sander, T Hildmann, T F Wienker, et al.
Journal of Internal Medicine|July 7, 2017
Impact of immunosuppressive therapy on therapy-neutralizing antibodies in transplanted patients with Fabry diseaseM Lenders, D Oder, A Nowak, et al.
Acta Neurologica Scandinavica|July 1, 1997
Linkage analysis between idiopathic generalized epilepsies and the GABA(A) receptor alpha5, beta3 and gamma3 subunit gene cluster on chromosome 15T Sander, R Kretz, M P Williamson, et al.
Epilepsy Research|April 1, 1996
Exclusion of linkage between idiopathic generalized epilepsies and the GABAA receptor alpha 1 and gamma 2 subunit gene cluster on chromosome 5T Sander, T Hildmann, D Janz, et al.
Neurology|August 26, 2011
Factors influencing in-hospital mortality and morbidity in patients treated on a stroke unitHans-Christian Koennecke, W Belz, D Berfelde, et al.
Urologic Oncology|October 20, 2022
Biology of BCG response in non-muscle invasive bladder cancer - 2021 IBCN Updates Part IIIM J Reike, M A Ingersoll, D C Müller, et al.
The British Journal of Dermatology|February 13, 2018
A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapyC A Morton, R Dominicus, P Radny, et al.
The British Journal of Dermatology|September 14, 2011
Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placeboT Dirschka, P Radny, R Dominicus, et al.
The British Journal of Dermatology|December 21, 2012
Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosisT Dirschka, P Radny, R Dominicus, et al.
Pageof 24

Showing results (231-240 of 239) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 239 results.
American Journal of Medical Genetics|February 16, 1996
Common subtypes of idiopathic generalized epilepsies: lack of linkage to D20S19 close to candidate loci (EBN1, EEGV1) on chromosome 20T Sander, T Hildmann, T F Wienker, et al.
Journal of Internal Medicine|July 7, 2017
Impact of immunosuppressive therapy on therapy-neutralizing antibodies in transplanted patients with Fabry diseaseM Lenders, D Oder, A Nowak, et al.
Acta Neurologica Scandinavica|July 1, 1997
Linkage analysis between idiopathic generalized epilepsies and the GABA(A) receptor alpha5, beta3 and gamma3 subunit gene cluster on chromosome 15T Sander, R Kretz, M P Williamson, et al.
Epilepsy Research|April 1, 1996
Exclusion of linkage between idiopathic generalized epilepsies and the GABAA receptor alpha 1 and gamma 2 subunit gene cluster on chromosome 5T Sander, T Hildmann, D Janz, et al.
Neurology|August 26, 2011
Factors influencing in-hospital mortality and morbidity in patients treated on a stroke unitHans-Christian Koennecke, W Belz, D Berfelde, et al.
Urologic Oncology|October 20, 2022
Biology of BCG response in non-muscle invasive bladder cancer - 2021 IBCN Updates Part IIIM J Reike, M A Ingersoll, D C Müller, et al.
The British Journal of Dermatology|February 13, 2018
A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapyC A Morton, R Dominicus, P Radny, et al.
The British Journal of Dermatology|September 14, 2011
Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placeboT Dirschka, P Radny, R Dominicus, et al.
The British Journal of Dermatology|December 21, 2012
Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosisT Dirschka, P Radny, R Dominicus, et al.
Pageof 24